OR Royalties (NYSE:OR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of OR Royalties (NYSE:OR) from a buy rating to a strong-buy rating in a report issued on Monday morning.

Several other equities research analysts have also weighed in on OR. Scotiabank lowered shares of OR Royalties from an “outperform” rating to a “sector perform” rating and increased their price objective for the stock from $33.00 to $41.00 in a research note on Thursday, October 23rd. Raymond James Financial upgraded OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 price target on the stock in a research report on Thursday, November 6th. Zacks Research lowered OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Friday, December 19th. Weiss Ratings restated a “buy (b)” rating on shares of OR Royalties in a research note on Monday, December 29th. Finally, Canaccord Genuity Group raised OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.75.

OR Royalties Price Performance

OR Royalties stock opened at $43.34 on Monday. The company has a market cap of $8.11 billion, a PE ratio of 54.86 and a beta of 0.78. The company has a fifty day moving average price of $36.10 and a two-hundred day moving average price of $33.95. OR Royalties has a 12 month low of $17.55 and a 12 month high of $44.95.

OR Royalties (NYSE:OR) last issued its earnings results on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. The company had revenue of $71.63 million for the quarter, compared to analysts’ expectations of $53.85 million. Equities research analysts anticipate that OR Royalties will post 0.62 earnings per share for the current year.

OR Royalties Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were paid a dividend of $0.055 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This represents a $0.22 annualized dividend and a yield of 0.5%. OR Royalties’s payout ratio is presently 27.85%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Caitlin John LLC bought a new stake in shares of OR Royalties during the third quarter valued at about $78,000. Eagle Global Advisors LLC acquired a new position in OR Royalties during the 3rd quarter valued at about $206,000. Merit Financial Group LLC bought a new stake in shares of OR Royalties during the 3rd quarter worth about $215,000. Flow Traders U.S. LLC acquired a new stake in shares of OR Royalties in the 3rd quarter worth approximately $217,000. Finally, Moors & Cabot Inc. acquired a new stake in shares of OR Royalties in the 3rd quarter worth approximately $220,000. Institutional investors own 68.52% of the company’s stock.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.